METABOLIC EXPLORER |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.163 EUR | +1.24% |
|
-5.78% | -57.99% |
| 03-20 | METabolic EXplorer: Noovistago on the road to reorganization | CF |
| 03-12 | METabolic EXplorer: applies for safeguard proceedings | CF |
| Sales 2021 | 172M 183M 14.69B | Sales 2022 | 228M 244M 19.54B | Capitalization | 53M 56.67M 4.54B |
|---|---|---|---|---|---|
| Net income 2021 | 84M 89.81M 7.19B | Net income 2022 | -50M -53.46M -4.28B | EV / Sales 2021 | 1.61 x |
| Net cash position 2021 | 14.89M 15.92M 1.27B | Net Debt 2022 | 38.37M 41.02M 3.29B | EV / Sales 2022 | 0.4 x |
| P/E ratio 2021 |
3.13
x | P/E ratio 2022 |
-1.04
x | Employees | 450 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.23% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +1.24% | ||
| 1 week | -5.78% | ||
| Current month | +14.47% | ||
| 1 month | +13.67% | ||
| 3 months | -56.12% | ||
| 6 months | -29.59% | ||
| Current year | -57.99% |
1 week
0.16
0.18
1 month
0.130.20
Current year
0.130.58
1 year
0.131.22
3 years
0.137.16
5 years
0.137.16
10 years
0.137.35
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 31/12/98 | |
Laurent Bastian
DFI | Director of Finance/CFO | 56 | - |
Nelly Faucheux
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 31/12/98 | |
Daniel Chron
BRD | Director/Board Member | 73 | 31/12/14 |
Hans Vogelsang
BRD | Director/Board Member | 81 | 31/12/07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.163 | +1.24% | 70,632 |
| 25/04/24 | 0.161 | -4.05% | 35,657 |
| 24/04/24 | 0.1678 | -2.67% | 60,574 |
| 23/04/24 | 0.1724 | -3.04% | 36,479 |
| 22/04/24 | 0.1778 | +2.77% | 149,490 |
Real-time Euronext Paris, April 26, 2024 at 04:35 pm
More quotes
Based on renewable raw materials, METabolic EXplorer develops and industrializes innovative and competitive fermentation processes that can serve as alternatives to petrochemical processes. Its ultimate goal is to meet the new societal expectations of consumers as well as the challenges of energy transition and sustainable development. Its functional ingredients of natural origin are used in the formulation of cosmetic products, animal nutrition and health, and as intermediates for the synthesis of biomaterials.
With more than 20 years of experience in industrial biochemistry, METabolic EXplorer aims to contribute to a new way of producing consumer products without oil.
Its biotechnological innovations rely on 460 employees whose complementary skills enable them to master all stages of process development.
Sector
Commodity Chemicals
Calendar
13/05/2024
- Q1 2024 Sales and Revenue Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -57.99% | 8.83M | |
| +5.14% | 103B | |
| -5.63% | 63.04B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.41% | 33.24B | |
| +6.85% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
- Stock Market
- Equities
- METEX Stock
